Savage, Bennicasa win Nexus Awards

Share this article:
Advanstar's Debby Savage and Pharmaceutical Media Inc.'s Gina Bennicasa won the Association of Medical Media's 17th annual Nexus Representatives of the Year Awards, honoring outstanding sales professionals in medical publishing. 

Savage won the award for multi-specialty publication for her work on Medical Economics. Bennicasa, of PMI, a New York City marketing and sales representation firm, won the award for specialty publication for her work representing Elsevier's American College of Cardiology properties, both print and online. “It's the greatest honor your clients can give you,” said Savage of the award. “It comes from them.”

The awards luncheon was held at the Palace Hotel in midtown Manhattan on March 10. Keynote speaker Harry Sweeney, formerly of Dorland Global and now managing partner, SouthPennSquare Associates, discussed the journal advertising recession and laced into marketers pulling back on print ads, noting AMM research showing that journal ads deliver a higher ROI than any other channel. “What part of number one don't these people get?” asked Sweeney. “Why are pages dropping in the face of this evidence?” He added, getting a guffaw out of the crowd: “Are you the worst sales people in the world?”  

The awards honor two people who have demonstrated the ability to keep advertisers connected to what's new in the industry, the market and the media. 
Share this article:

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...